...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: New MD&A posted

At least we kniw the direction they want to take now.

On July 31, 2018, we announced that we intended to pursue a listing of our common shares in the United States. We intend to partner for future clinical development of apabetalone; therefore, we no longer intend to list our common shares in the United States.      

Share
New Message
Please login to post a reply